Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences buys BMEYE for $42 mil. Sapien valve sales in Q3 fall below firm’s expectations. Hospira draws FDA warning letter. More news briefs.


Related Content

FDA Clears Edwards’ Non-Invasive Hemodynamic Monitor For High-Risk Surgical Patients
FDA Hits Baxter With Two Warning Letters In Four Weeks
Reimbursement Briefs: OIG Looks At DME; AHRQ Seeks Imaging Info; MolDx News
Reimbursement In Brief
Veracyte Meets New Medicare Coverage Mandate For Molecular Dx
Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls
NIH Leads Aggressive Push To Lower Radiation Doses In CT Scans


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts